GlassScriptPhysician profile
Subhransu Kumar Ray
NPI 1578597878
$16,379.45
in general payments reported to CMS, 2019-2025
20 companies · $889 in 2025
The $889 reported for 2025 was more than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,241 · 2020: $150 · 2021: $148 · 2022: $4,831 · 2023: $689 · 2024: $3,431 · 2025: $889.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,509 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,509.39 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,790.19 | 2022-2024 | |
| Carl Zeiss Meditec, INC. | $4,000.00 | 2019 | |
| Genentech USA, INC. | $985.60 | 2019-2025 | Vabysmo |
| Novartis Pharmaceuticals Corporation | $909.43 | 2019-2021 | |
| Alcon Vision LLC | $611.06 | 2019-2025 | Hydrus Microstent, Clareon, Constellation |
| Alimera Sciences, INC. | $520.27 | 2019-2024 | Yutiq, Iluvien |
| Regeneron Healthcare Solutions, INC. | $468.26 | 2019-2025 | Eylea, Eylea Hd |
| Mallinckrodt Hospital Products INC. | $415.32 | 2022-2025 | Acthar |
| Astellas Pharma US INC | $388.42 | 2023-2025 | Izervay |
| Genentech, INC. | $290.02 | 2019 | |
| Apellis Pharmaceuticals, INC. | $280.34 | 2023-2025 | Syfovre |
| Ani Pharmaceuticals, INC. | $201.03 | 2025 | Yutiq, Iluvien, Purified Cortrophin Gel |
| Abbvie INC. | $143.09 | 2024-2025 | |
| Kala Pharmaceuticals, INC. | $124.85 | 2019 | |
| Allergan, INC. | $101.41 | 2019-2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $66.38 | 2022-2023 | |
| Ivantis, INC | $24.13 | 2021 | |
| Sun Pharmaceutical Industries INC. | $24.04 | 2019 | |
| Mallinckrodt Enterprises LLC | $19.14 | 2019 | |
| Optos, INC. | $16.47 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Subhransu Ray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.